Literature DB >> 1406695

A Raf-1-related p110 polypeptide associates with the CD4-p56lck complex in T cells.

K V Prasad1, C E Rudd.   

Abstract

The CD4 and CD8 antigens on T cells have been shown to associate with the Src family member p56lck and a GTP-binding protein, p32. The identification of receptor interactions with intracellular mediators is essential in the elucidation of downstream signals mediated by engagement of these receptor complexes. In this study, we report the detection of an additional 110-kDa polypeptide (p110) associated with the CD4-p56lck complex in human peripheral blood T lymphocytes and leukemic T-cell lines. p110 bound preferentially to CD4-p56lck as an assembled complex and poorly, if at all, to the individual components. p110 was recognized directly by an antiserum to the C-terminal region of the serine/threonine kinase Raf-1 and is related to a p110 polypeptide detected in anti-Raf-1 immunoprecipitates. Despite its association with the CD4-p56lck complex, p110 was found to be phosphorylated predominantly on serine residues. Furthermore, phorbol ester treatment of cells resulted in a transient increase in the detection of p110 associated with CD4-p56lck, concomitant with the modulation of CD4-p56lck from the cell surface. This Raf-1-related p110 is therefore likely to play a role in signals generated from the CD4-p56lck complex. p110 may serve as a bridge between the CD4-p56lck complex and the serine/threonine kinase pathways of T-cell activation.

Entities:  

Mesh:

Substances:

Year:  1992        PMID: 1406695      PMCID: PMC360459          DOI: 10.1128/mcb.12.11.5260-5267.1992

Source DB:  PubMed          Journal:  Mol Cell Biol        ISSN: 0270-7306            Impact factor:   4.272


  60 in total

1.  Requirement for association of p56lck with CD4 in antigen-specific signal transduction in T cells.

Authors:  N Glaichenhaus; N Shastri; D R Littman; J M Turner
Journal:  Cell       Date:  1991-02-08       Impact factor: 41.582

Review 2.  T-cell development and transmembrane signaling: changing biological responses through an unchanging receptor.

Authors:  T H Finkel; R T Kubo; J C Cambier
Journal:  Immunol Today       Date:  1991-02

Review 3.  Oncogenes and signal transduction.

Authors:  L C Cantley; K R Auger; C Carpenter; B Duckworth; A Graziani; R Kapeller; S Soltoff
Journal:  Cell       Date:  1991-01-25       Impact factor: 41.582

Review 4.  T cell antigen receptor activation pathways: the tyrosine kinase connection.

Authors:  R D Klausner; L E Samelson
Journal:  Cell       Date:  1991-03-08       Impact factor: 41.582

5.  An inhibitory mutant of c-Raf-1 blocks v-Src-induced activation of the Egr-1 promoter.

Authors:  S A Qureshi; M Rim; J Bruder; W Kolch; U Rapp; V P Sukhatme; D A Foster
Journal:  J Biol Chem       Date:  1991-11-05       Impact factor: 5.157

Review 6.  T-lymphocyte recognition of antigen in association with gene products of the major histocompatibility complex.

Authors:  R H Schwartz
Journal:  Annu Rev Immunol       Date:  1985       Impact factor: 28.527

7.  Association of the fyn protein-tyrosine kinase with the T-cell antigen receptor.

Authors:  L E Samelson; A F Phillips; E T Luong; R D Klausner
Journal:  Proc Natl Acad Sci U S A       Date:  1990-06       Impact factor: 11.205

Review 8.  The T cell receptor/CD3 complex: a dynamic protein ensemble.

Authors:  H Clevers; B Alarcon; T Wileman; C Terhorst
Journal:  Annu Rev Immunol       Date:  1988       Impact factor: 28.527

9.  Transactivation of c-fos and beta-actin genes by raf as a step in early response to transmembrane signals.

Authors:  S Jamal; E Ziff
Journal:  Nature       Date:  1990-03-29       Impact factor: 49.962

10.  Raf-1 protein kinase is required for growth of induced NIH/3T3 cells.

Authors:  W Kolch; G Heidecker; P Lloyd; U R Rapp
Journal:  Nature       Date:  1991-01-31       Impact factor: 49.962

View more
  9 in total

1.  Downregulation of Lck-mediated signal transduction by tip of herpesvirus saimiri.

Authors:  J U Jung; S M Lang; T Jun; T M Roberts; A Veillette; R C Desrosiers
Journal:  J Virol       Date:  1995-12       Impact factor: 5.103

Review 2.  Envelope glycoproteins of human immunodeficiency virus type 1: profound influences on immune functions.

Authors:  N Chirmule; S Pahwa
Journal:  Microbiol Rev       Date:  1996-06

3.  The protein tyrosine kinase p56lck is required for triggering NF-kappaB activation upon interaction of human immunodeficiency virus type 1 envelope glycoprotein gp120 with cell surface CD4.

Authors:  L Briant; V Robert-Hebmann; C Acquaviva; A Pelchen-Matthews; M Marsh; C Devaux
Journal:  J Virol       Date:  1998-07       Impact factor: 5.103

Review 4.  The role of glycosphingolipids in HIV signaling, entry and pathogenesis.

Authors:  Mathias Viard; Isabella Parolini; Satinder S Rawat; Katia Fecchi; Massimo Sargiacomo; Anu Puri; Robert Blumenthal
Journal:  Glycoconj J       Date:  2004       Impact factor: 2.916

5.  HIV-induced apoptosis requires the CD4 receptor cytoplasmic tail and is accelerated by interaction of CD4 with p56lck.

Authors:  J Corbeil; M Tremblay; D D Richman
Journal:  J Exp Med       Date:  1996-01-01       Impact factor: 14.307

6.  Human spleen tyrosine kinase p72Syk associates with the Src-family kinase p53/56Lyn and a 120-kDa phosphoprotein.

Authors:  S P Sidorenko; C L Law; K A Chandran; E A Clark
Journal:  Proc Natl Acad Sci U S A       Date:  1995-01-17       Impact factor: 11.205

7.  Phosphatidylinositol (PI) 3-kinase and PI 4-kinase binding to the CD4-p56lck complex: the p56lck SH3 domain binds to PI 3-kinase but not PI 4-kinase.

Authors:  K V Prasad; R Kapeller; O Janssen; H Repke; J S Duke-Cohan; L C Cantley; C E Rudd
Journal:  Mol Cell Biol       Date:  1993-12       Impact factor: 4.272

8.  Conditionally oncogenic forms of the A-Raf and B-Raf protein kinases display different biological and biochemical properties in NIH 3T3 cells.

Authors:  C A Pritchard; M L Samuels; E Bosch; M McMahon
Journal:  Mol Cell Biol       Date:  1995-11       Impact factor: 4.272

9.  Raf-1 is required for T cell IL2 production.

Authors:  H Owaki; R Varma; B Gillis; J T Bruder; U R Rapp; L S Davis; T D Geppert
Journal:  EMBO J       Date:  1993-11       Impact factor: 11.598

  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.